Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...
New appointees to Board and Leadership team bring global strategic, operational and commercial experience from across the medical device sector. New headquarters and state-of-the-art manufacturing ...
Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress ...
Published in the Journal of Clinical Medicine, the study demonstrates that administering treatment of migraine with Remote Electrical Neuromodulation (REN) does not impact blood s ...
On 20 February 2026, Orrum Clinical Analytics announced a partnership with LivaNova USA Inc. to link LivaNova’s Essenz Perfusion System with Orrum’s CORE Insights platform, enabling secure, automatic ...
Globus Medical cites successful integration of NuVasive and Nervo and strong domestic spine sales growth as drivers in strong Q4 results.
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsBrian Kearns - Senior Vice President of ...
K Additive signed a global long?term supply agreement under which Siemens Energy will supply spent nickel alloy powder from its additive manufacturing facilities to 6K Additive for use as feedstock in ...
Pain Management Devices Market OutlookThe global pain management devices market is projected to expand at a compound annual growth rate (CAGR) of approximately 9% over the forecast period, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results